GNH USA

Europe — EMA

Miacalcic

GNH USA supplies Miacalcic (Calcitonin Salmon), a calcitonin for osteoporosis, Paget disease and hypercalcemia of malignancy. Request a quote for supply.

Calcitonin Salmon, Synthetic

Request sourcing

1
Pack/s

What is Calcitonin Salmon, Synthetic?

Calcitonin Salmon, the active ingredient in Miacalcic, is a calcitonin presented as an injection solution for intramuscular, intravenous, and subcutaneous use. It treats postmenopausal osteoporosis, Paget disease of bone, and hypercalcemia of malignancy.

GNH USA supplies Miacalcic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, transplant centres, pharmacies and clinics worldwide.

What is Calcitonin Salmon, Synthetic used for?

Miacalcic, a calcitonin analogue, acts on bone metabolism and calcium regulation.

Postmenopausal osteoporosis: reduces bone loss and fracture risk. Paget disease of bone: normalizes bone turnover and alleviates pain. Hypercalcemia of malignancy: lowers elevated serum calcium levels.

What are the side effects of Calcitonin Salmon, Synthetic?

Miacalcic may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Flushing: transient warmth and redness. - Injection site reaction: pain, erythema or swelling. - Headache: mild to moderate. - Dizziness: occasional light‑headedness. - Mild hypocalcemia: transient low calcium levels.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response. - Severe hypocalcemia: can lead to cardiac arrhythmia or seizures. - Cardiovascular collapse: sudden drop in blood pressure. - Severe injection site necrosis: tissue damage at the site. - Acute pancreatitis: rare inflammatory pancreas condition.

What precautions apply to Calcitonin Salmon, Synthetic?

When using Miacalcic, consider the following precautions. - Renal impairment: monitor calcium and adjust dose. - Existing hypocalcemia: avoid use until corrected. - Pregnancy: safety not established, use only if benefit outweighs risk. - Pediatric use: not recommended unless specifically indicated. - Concurrent anti‑resorptives: assess for additive effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

What does Calcitonin Salmon, Synthetic interact with?

Miacalcic can interact with several medicines; awareness helps manage risk.

Major Interactions (Avoid): - Other calcitonin products: risk of overdose. - High‑dose calcium supplements: may blunt therapeutic effect. - Bisphosphonates: potential antagonistic effect on bone turnover. - Systemic corticosteroids: may reduce calcitonin efficacy. - Warfarin: altered calcium metabolism may affect anticoagulation.

Moderate Interactions (Monitor Closely): - NSAIDs: increased risk of gastrointestinal irritation. - Loop diuretics: may exacerbate calcium loss. - Antacids containing aluminum or magnesium: may affect absorption.

Frequently asked questions

What is Miacalcic used for?+
Miacalcic contains synthetic salmon calcitonin and is prescribed for conditions where bone turnover is excessive or serum calcium is elevated, specifically postmenopausal osteoporosis, Paget disease of bone, and hypercalcemia associated with malignancy. It helps reduce bone loss, normalize bone remodeling, and lower calcium levels under medical supervision.
How does calcitonin salmon work?+
Synthetic salmon calcitonin binds to calcitonin receptors located on osteoclast cells. This binding inhibits osteoclast activity, decreasing bone resorption and consequently lowering the release of calcium from bone into the bloodstream. The reduced calcium release also contributes to lower serum calcium concentrations in hypercalcemic states.
What is the usual dose of Miacalcic?+
The dosage of Miacalcic is determined by the prescribing clinician based on the specific indication, patient characteristics, and route of administration (intramuscular, intravenous, or subcutaneous). Healthcare professionals follow approved labeling and clinical guidelines to select the appropriate amount and frequency for each individual patient.
Is Miacalcic safe in pregnancy or breastfeeding?+
The safety of synthetic salmon calcitonin during pregnancy and lactation has not been definitively established. Consequently, it should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Miacalcic from GNH USA?+
To place an order, visit the product page on gnh-usa.com, enter the required quantity, and submit the enquiry form. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where needed) and necessary import documentation.
How does Miacalcic compare with other bone‑resorptive agents?+
Compared with bisphosphonates, calcitonin provides a rapid but generally less potent inhibition of bone resorption and is often used when a short‑term reduction in calcium is needed, such as in hypercalcemia of malignancy. Unlike bisphosphonates, calcitonin is administered by injection and may be preferred in patients who cannot tolerate oral agents, though long‑term efficacy for osteoporosis is lower.
What are the storage requirements for Miacalcic?+
Miacalcic should be stored at 2‑8 °C (refrigerated) in its original packaging. Protect the product from light, do not freeze, and avoid shaking the vial. If temperature excursions occur, discard the product according to local regulations and consult the supplier for replacement.
How is Miacalcic administered?+
Miacalcic is supplied as a sterile injection solution and can be given intramuscularly, intravenously, or subcutaneously, depending on the clinical indication and physician preference. Administration is performed by a qualified healthcare professional using aseptic technique, and the injection site should be rotated when multiple doses are required to minimize local reactions.
What are the most serious risks associated with Miacalcic?+
The most serious adverse reactions to synthetic salmon calcitonin include severe hypersensitivity or anaphylactic responses, profound hypocalcemia that may cause cardiac arrhythmias or seizures, and rare cases of cardiovascular collapse. Patients should be monitored for signs of allergic reaction and for rapid drops in serum calcium, especially during the initial dosing period.
Who should not use Miacalcic?+
Miacalcic is contraindicated in individuals with known hypersensitivity to salmon calcitonin or any component of the formulation. It should also be avoided in patients with severe renal impairment, uncontrolled hypocalcemia, or those who have experienced severe allergic reactions to previous calcitonin therapy. Clinicians must assess each patient’s medical history before initiating treatment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Calcitonin Salmon, Synthetic
Route
Intramuscular Use , Intravenous Use , Subcutaneous
Manufacturer
Essential Pharma (M) Limited
Origin
EU

Related products